Add
ILI to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| ILI > SEC Filings for ILI > Form 8-K on 13-Nov-2008 | All Recent SEC Filings |
13-Nov-2008
Results of Operations and Financial Condition, Financial Statements and
On November 13, 2008, Interleukin Genetics, Inc. issued a press release to report its consolidated financial results for its quarter ended September 30, 2008. A copy of that press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
The information set forth in Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
(d) The following exhibit is furnished with this report:
Exhibit No. Description
99.1 Earnings Press Release dated November 13, 2008.
|
|